1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
-
Mark
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling
(
- Contribution to journal › Article
-
Mark
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis
(
- Contribution to journal › Article
-
Mark
IL1RAP Blockade with a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis
(
- Contribution to journal › Article
- 2021
-
Mark
IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice
(
- Contribution to journal › Article
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Atherosclerosis : cell biology and lipoproteins
(
- Contribution to journal › Article
-
Mark
Increased lymphocyte activation and atherosclerosis in CD47-deficient mice
(
- Contribution to journal › Article